The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Cooke, Colin R ^a   Joo, Min J ^b,c   Anderson, Stephen M ^d   Lee, Todd A ^b,c   Udris, Edmunds M ^d   Johnson, Eric ^e   Au, David H ^d,f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HINES VA HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GOVERNMENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICAL RECORD; MIDDLE AGED; PHARMACY; STATISTICAL MODEL; STATISTICS; UNITED STATES; VALIDATION STUDY;

AGED; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; PHARMACIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 79951556584     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-37     Document Type: Article

References (46)

1. Chronic obstructive pulmonary disease: current burden and future projections. AD Lopez K Shibuya C Rao CD Mathers AL Hansell LS Held V Schmid S Buist, Eur Respir J 2006 27 2 397 412 10.1183/09031936.06.00025805 16452599 (Pubitemid 43180921)
2. The most expensive medical conditions in America. BG Druss SC Marcus M Olfson HA Pincus, Health Aff (Millwood) 2002 21 4 105 111 10.1377/hlthaff.21.4. 105 12117121
3. The economic burden of COPD. SD Sullivan SD Ramsey TA Lee, Chest 2000 117 2 Suppl 5S 9S 10.1378/chest.117.2-suppl.5S 10673466 (Pubitemid 30111556)
4. Update in chronic obstructive pulmonary disease 2008. JD Maclay RA Rabinovich W MacNee, Am J Respir Crit Care Med 2009 179 7 533 541 10.1164/rccm.200901-0134UP 19318543
5. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. KF Rabe S Hurd A Anzueto PJ Barnes SA Buist P Calverley Y Fukuchi C Jenkins R Rodriguez-Roisin C van Weel, et al. Am J Respir Crit Care Med 2007 176 6 532 555 10.1164/rccm.200703- 456SO 17507545 (Pubitemid 47403272)
6. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. BR Celli W MacNee, Eur Respir J 2004 23 6 932 946 10.1183/09031936.04.00014304 15219010 (Pubitemid 38807371)
7. Interpreting COPD prevalence estimates: what is the true burden of disease? RJ Halbert S Isonaka D George A Iqbal, Chest 2003 123 5 1684 1692 10.1378/chest.123.5.1684 12740290 (Pubitemid 36549792)
8. Global burden of COPD: systematic review and meta-analysis. RJ Halbert JL Natoli A Gano E Badamgarav AS Buist DM Mannino, Eur Respir J 2006 28 3 523 532 10.1183/09031936.06.00124605 16611654 (Pubitemid 44794666)
9. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. AS Buist MA McBurnie WM Vollmer S Gillespie P Burney DM Mannino AMB Menezes SD Sullivan TA Lee KB Weiss, et al. The Lancet 2007 370 9589 741 750 10.1016/S0140-6736(07)61377-4 (Pubitemid 47321907)
10. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. AS Gershon C Wang AS Wilton R Raut T To, Arch Intern Med 2010 170 6 560 565 10.1001/archinternmed.2010.17 20308643
11. Inhaled corticosteroids and mortality in COPD. C Macie K Wooldrage J Manfreda NR Anthonisen, Chest 2006 130 3 640 646 10.1378/chest.130.3.640 16963657
12. Spirometry utilization for COPD: how do we measure up? MK Han MG Kim R Mardon P Renner S Sullivan GB Diette FJ Martinez, Chest 2007 132 2 403 409 10.1378/chest.06-2846 17550936 (Pubitemid 47282369)
13. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. TA Lee AS Pickard DH Au B Bartle KB Weiss, Ann Intern Med 2008 149 6 380 390 18794557
14. Burden of concomitant asthma and COPD in a Medicaid population. FT Shaya D Dongyi MO Akazawa CM Blanchette J Wang DW Mapel A Dalal SM Scharf, Chest 2008 134 1 14 19 10.1378/chest.07-2317 18339789 (Pubitemid 352008758)
15. Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. FT Shaya MS Maneval CM Gbarayor K Sohn AA Dalal D Du SM Scharf, Chest 2009 136 2 405 411 10.1378/chest.08-2304 19318663
16. Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department. AA Ginde CL Tsai PG Blanc CA Camargo Jr, Jt Comm J Qual Patient Saf 2008 34 11 678 680 19025089
17. National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993-2005. CL Tsai JA Sobrino CA Camargo Jr, Acad Emerg Med 2008 15 12 1275 1283 10.1111/j.1553-2712.2008.00284.x 18976335
18. The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. GR Washko VS Fan SD Ramsey Z Mohsenifar F Martinez BJ Make FC Sciurba GJ Criner O Minai MM Decamp, et al. Am J Respir Crit Care Med 2008 177 2 164 169 10.1164/rccm.200708-1194OC 17962632
19. Identifying individuals with physician diagnosed COPD in health administrative databases. AS Gershon C Wang J Guan J Vasilevska-Ristovska L Cicutto T To, Copd 2009 6 5 388 394 10.1080/15412550903140865 19863368
20. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. NS Rawson E Malcolm, Stat Med 1995 14 24 2627 2643 10.1002/sim.4780142404 8619104 (Pubitemid 26014254)
21. An algorithm for the identification of undiagnosed COPD cases using administrative claims data. DW Mapel FJ Frost JS Hurley H Petersen M Roberts JP Marton H Shah, J Manag Care Pharm 2006 12 6 457 465 16925453
22. A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J McKnight A Scott D Menzies J Bourbeau L Blais C Lemiere, J Clin Epidemiol 2005 58 2 206 208 10.1016/j.jclinepi.2004.08.006 15680756 (Pubitemid 40174931)
23. The validity of diagnosing chronic obstructive pulmonary disease from a large administrative database. Y Lacasse VM Montori C Lanthier F Maltis, Can Respir J 2005 12 5 251 256 16107913 (Pubitemid 41387422)
24. The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia. PG Camp M Chaudhry H Platt M Roch J Road D Sin RD Levy, Can Respir J 2008 15 8 417 422 19107241
25. Population impact of different definitions of airway obstruction. BR Celli RJ Halbert S Isonaka B Schau, Eur Respir J 2003 22 2 268 273 10.1183/09031936.03.00075102 12952259 (Pubitemid 36986996)
26. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. MP Swanney G Ruppel PL Enright OF Pedersen RO Crapo MR Miller RL Jensen E Falaschetti JP Schouten JL Hankinson, et al. Thorax 2008 63 12 1046 1051 10.1136/thx.2008.098483 18786983
27. Spirometric reference values from a sample of the general U.S. population. JL Hankinson JR Odencrantz KB Fedan, Am J Respir Crit Care Med 1999 159 1 179 187 9872837 (Pubitemid 29036522)
28. Standardisation of spirometry. MR Miller J Hankinson V Brusasco F Burgos R Casaburi A Coates R Crapo P Enright CP van der Grinten P Gustafsson, et al. Eur Respir J 2005 26 2 319 338 10.1183/09031936.05.00034805 16055882 (Pubitemid 41079078)
29. Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. JV Tu, J Clin Epidemiol 1996 49 11 1225 1231 10.1016/S0895-4356(96)00002-9 8892489 (Pubitemid 26386228)
30. Predicting hospital mortality for patients in the intensive care unit: a comparison of artificial neural networks with logistic regression models. G Clermont DC Angus SM DiRusso M Griffin WT Linde-Zwirble, Crit Care Med 2001 29 2 291 296 10.1097/00003246-200102000-00012 11246308 (Pubitemid 32171773)
31. Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. LM Lix MS Yogendran WD Leslie SY Shaw R Baumgartner C Bowman C Metge A Gumel J Hux RC James, J Clin Epidemiol 2008 61 12 1250 1260 10.1016/j.jclinepi.2008.02.002 18619800
32. Information theory and an extension of the maximum likelihood principle. H Akaike, Proceedings of the 2nd International Symposium on Information Theory 1973
33. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. EW Steyerberg FE Harrell Jr GJ Borsboom MJ Eijkemans Y Vergouwe JD Habbema, J Clin Epidemiol 2001 54 8 774 781 10.1016/S0895-4356(01)00341-9 11470385 (Pubitemid 32722180)
34. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists. DW Mapel JS Hurley D Roblin M Roberts KJ Davis R Schreiner FJ Frost, Respir Med 2006 100 4 595 609 10.1016/j.rmed.2005.08.006 16199151 (Pubitemid 43285746)
35. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. VS Fan SD Ramsey ND Giardino BJ Make CF Emery PT Diaz JO Benditt Z Mosenifar R McKenna Jr JL Curtis, et al. Arch Intern Med 2007 167 21 2345 2353 10.1001/archinte.167.21.2345 18039994 (Pubitemid 350179530)
36. Medication adherence and persistence in the last year of life in COPD patients. E Jung AS Pickard JW Salmon B Bartle TA Lee, Respir Med 2009 103 4 525 534 10.1016/j.rmed.2008.11.004 19136240
37. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. DD Sin JV Tu, Am J Respir Crit Care Med 2001 164 4 580 584 11520719 (Pubitemid 32801660)
38. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. T Parimon JW Chien CL Bryson MB McDonell EM Udris DH Au, Am J Respir Crit Care Med 2007 175 7 712 719 10.1164/rccm.200608-1125OC 17185647 (Pubitemid 46536487)
39. Guide to prevention quality indicators: hospital admission for ambulatory care sensitive conditions [version 3.1]. AHRQ quality indicators, Rockville (MD): Agency for Healthcare Research and Quality (AHRQ) 2007 12. 59 (AHRQ Pub; no. 02-R0203)
40. HEDIS 2008: Healthcare Effectiveness Data & Information Set. National Committee for Quality Assurance (NCQA), Technical Specifications Washington (DC): National Committee for Quality Assurance (NCQA) 2007 2 various p
41. Physician perceptions and management of COPD. S Kesten KR Chapman, Chest 1993 104 1 254 258 10.1378/chest.104.1.254 8325079 (Pubitemid 23204566)
42. Gender bias in the diagnosis of COPD. KR Chapman DP Tashkin DJ Pye, Chest 2001 119 6 1691 1695 10.1378/chest.119.6.1691 11399692 (Pubitemid 32744923)
43. Spirometry use in clinical practice following diagnosis of COPD. TA Lee B Bartle KB Weiss, Chest 2006 129 6 1509 1515 10.1378/chest.129.6.1509 16778268 (Pubitemid 43894979)
44. Assessing the accuracy of administrative data in health information systems. JW Peabody J Luck S Jain D Bertenthal P Glassman, Med Care 2004 42 11 1066 1072 10.1097/00005650-200411000-00005 15586833 (Pubitemid 39472113)
45. External validation is necessary in prediction research: a clinical example. SE Bleeker HA Moll EW Steyerberg AR Donders G Derksen-Lubsen DE Grobbee KG Moons, J Clin Epidemiol 2003 56 9 826 832 10.1016/S0895-4356(03)00207-5 14505766 (Pubitemid 37162656)
46. Regional Variation in Health Status among Chronic Obstructive Pulmonary Disease Patients. VS Fan PO Bridevaux MB McDonell SD Fihn LM Besser DH Au, Respiration 2011 81 1 9 17 10.1159/000320115